PharmaStem Therapeutics Inc., of Wayne, Pa., was awarded U.S. Patent No...Vasogen Inc., of Toronto, received from the U.S. Patent and Trademark Office a notice of allowance for an application protecting the use of Vasogen's immune modulation therapy to treat chronic heart failure

Adolor Corp., of Exton, Pa., received U.S. Patent No...Aphios Corp., of Woburn, Mass., was granted U.S. Patent No...Biolog Inc., of Hayward, Calif., received U.S. Patent No

Ltd., of Brisbane, Australia, was awarded U.S. Patent No...MethylGene Inc., of Montreal, received U.S. Patent No...TopoTarget Prolifix A/S, of Copenhagen, Denmark, was granted U.S. Patent No

subsidiary received from the U.S. Patent and Trademark Office an allowance for a patent protecting intellectual property involving the mechanism of action for its lead anticancer drug, NC381...Medicure Inc., of Winnepeg, Manitoba, received U.S. Patent No

Alteon Inc., of Ramsey, N.J., was awarded U.S. Patent No...Aspira Biosystems Inc., of South San Francisco, received U.S. Patent No...Sonus Pharmaceuticals Inc., of Bothell, Wash., was awarded U.S. Patent No

Sangamo Biosciences Inc., of Richmond, Calif., was granted U.S. Patent No...Transmolecular Inc., of Birmingham, Ala., was awarded U.S. Patent Nos...Unigene Laboratories Inc., of Fairfield, N.J., was awarded U.S. Patent No

Inc., of Bothell, Wash., was issued U.S. Patent No...Of note, the company said, is U.S. Patent No...The company also was awarded U.S. Patent No

The company also was granted U.S. Patent No...Cepheid Inc., of Sunnyvale, Calif., was issued U.S. Patent No...Isolagen Inc., of Houston, was issued U.S. Patent No

Epimmune Inc., of San Diego, was issued U.S. Patent No...Nanotherapeutics Inc., of Alachua, Fla., was issued U.S. Patent No...Quark Biotech Inc., of Cleveland, was issued U.S. Patent No

Avigen Inc., of Alameda, Calif., was awarded U.S. Patent No...Endovasc Ltd., of Montgomery, Texas, was awarded U.S. Patent No...ZymoGenetics Inc., of Seattle, was awarded U.S. Patent No

Coley Pharmaceutical Group, of Wellesley, Mass., was awarded U.S. Patent No...Maxim Pharmaceuticals Inc., of San Diego, was awarded U.S. Patent No...NexMed Inc., of Robbinsville, N.J., received U.S. Patent No

Kosan Biosciences Inc., of Hayward, Calif., was awarded U.S. Patent No...Symyx Technologies Inc., of Santa Clara, Calif., was issued U.S. Patent No...Vical Inc., of San Diego, was issued U.S. Patent No

Hybridon Inc., of Cambridge, Mass., was issued U.S. Patent No...PerkinElmer Inc., of Boston, was issued U.S. Patent No...Pharmacor Inc., of Montreal, was issued U.S. Patent No

Nereus Pharmaceuticals Inc., of San Diego, was issued U.S. Patent No...SemBioSys Inc., of Calgary, Alberta, was granted U.S. Patent No...Vical Inc., of San Diego, was issued U.S. Patent No

Cepheid Inc., of Sunnyvale, Calif., was issued U.S. Patent No...Genset SA, of Paris, was issued U.S. Patent No...ZymoGenetics Inc., of Seattle, was issued U.S. Patent Nos

Diversa Corp., of San Diego, was issued U.S. Patent No...U.S. Genomics Inc., of Woburn, Mass., was issued U.S. Patent No...Viragen Inc., of Plantation, Fla., was issued U.S. Patent No

Hybridon Inc., of Cambridge, Mass., reported that the University of Massachusetts was issued U.S. Patent No...Isis Pharmaceuticals Inc., of Carlsbad, Calif., acquired a license to the patent, and others, in May 2001, from Hybridon, which included exclusive rights to sublicense the patents to third parties

Merrimack Pharmaceuticals Inc., of Cambridge, Mass., said U.S. Patent No...Microbiotix Inc., of Worcester, Mass., was issued U.S. Patent No...Peregrine Pharmaceuticals Inc., of Tustin, Calif., was issued U.S. Patent No

Neurochem Inc., of Saint-Laurent, Quebec, was issued U.S. Patent No...ProtoTech Inc., of Kirkland, Wash., said U.S. Patent No...Ribozyme Pharmaceuticals Inc., of Boulder, Colo., was issued U.S. Patent No